HER Salt Lake Initiative
HER-SL
Highly Effective Reversible Contraceptive Initiative-Salt Lake (HER-SL)
1 other identifier
observational
4,430
1 country
1
Brief Summary
This study aims to understand the long-term health, social, and economic impacts of transitioning a community to Highly Effective Reversible Contraception (HER-C).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2014
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2014
CompletedFirst Submitted
Initial submission to the registry
March 8, 2016
CompletedFirst Posted
Study publicly available on registry
April 12, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2020
CompletedApril 28, 2021
April 1, 2021
5.3 years
March 8, 2016
April 26, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Contraceptive method choice and continuation per participant report and medical record documentation
Assess contraceptive method choice and use in relation to participant demographic and socioeconomic characteristics at enrollment, 12 months, 24 months, and 36 months.
at enrollment through 36 months
Secondary Outcomes (1)
Federal Poverty Level (FPL) status by participant reported income
at enrollment through 36 months
Study Arms (3)
Enrollment Period 1 Cohort
Cohort 1 includes approximately 650 participants who receive a standardized client centered contraceptive counseling session with a clinical assistant. Contraceptive access will be the same as it was prior to the study beginning, meaning participants either have to use insurance or self-pay for their method of choice.
Enrollment Period 2 Cohort
Cohort 2 includes approximately 1000 participants who receive a standardized client centered contraceptive counseling session with a clinical assistant. Financial barriers are removed for Period 2 participants and they can initiate which ever contraceptive method they want at no cost to them for three years.
Enrollment Period 3 Cohort
Cohort 3 includes approximately 1350 participants who receive a standardized client centered contraceptive counseling session with a clinical assistant. Financial barriers are removed for Period 3 participants and they can initiate which ever contraceptive method they want at no cost to them for three years. During enrollment period 3, a community-wide, media driven intervention will be implemented and population level changes in HER-C initiation will be examined.
Eligibility Criteria
Females 16-45 years of age, who desire to prevent pregnancy for at least one year and are seeking contraceptive counseling and long term contraception services in Salt Lake County.
You may qualify if:
- Females
- years of age
- Seeking contraceptive counseling and services at four participating Planned Parenthood clinics in Salt Lake County
- Desire to prevent pregnancy for at least one year
- Fluent in English or Spanish
- Their current preferred phone number must be functioning at the time of study entry and will be tested prior to enrollment
You may not qualify if:
- Currently pregnant and planning to continue the pregnancy, or trying to get pregnant
- Relying on female or male sterilization as contraceptive method
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Utahlead
- William and Flora Hewlett Foundationcollaborator
- Society of Family Planningcollaborator
Study Sites (1)
Planned Parenthood Association of Utah
Salt Lake City, Utah, 84102, United States
Related Publications (8)
Simmons RG, Carter G, Sanders JN, Turok DK. Assessing Contraceptive Switching and Discontinuation Over 3 Years in the HER Salt Lake Study. Obstet Gynecol. 2024 Jul 1;144(1):79-88. doi: 10.1097/AOG.0000000000005621. Epub 2024 May 23.
PMID: 38781634DERIVEDGero A, Simmons RG, Sanders JN, Turok DK. Does access to no-cost contraception change method selection among individuals who report difficulty paying for health-related care? BMC Womens Health. 2022 Aug 2;22(1):327. doi: 10.1186/s12905-022-01911-x.
PMID: 35918666DERIVEDHiggins JA, Kramer R, Senderowicz L, Everett B, Turok DK, Sanders JN. Sex, poverty, and public health: Connections between sexual wellbeing and economic resources among US reproductive health clients. Perspect Sex Reprod Health. 2022 Mar;54(1):25-28. doi: 10.1363/psrh.12189. Epub 2022 Feb 27.
PMID: 35220665DERIVEDDalessandro C, Kaiser J, Sanders JN. Reproductive autonomy and feelings of control over pregnancy among emerging adult clients in a Utah (USA) contraceptive initiative study. Sex Reprod Healthc. 2022 Mar;31:100688. doi: 10.1016/j.srhc.2021.100688. Epub 2021 Nov 26.
PMID: 34864316DERIVEDKramer RD, Higgins JA, Everett B, Turok DK, Sanders JN. A prospective analysis of the relationship between sexual acceptability and contraceptive satisfaction over time. Am J Obstet Gynecol. 2022 Mar;226(3):396.e1-396.e11. doi: 10.1016/j.ajog.2021.10.008. Epub 2021 Oct 14.
PMID: 34656551DERIVEDMyers K, Sanders JN, Dalessandro C, Sexsmith CD, Geist C, Turok DK. The HER Salt Lake media campaign: comparing characteristics and outcomes of clients who make appointments online versus standard scheduling. BMC Womens Health. 2021 Mar 23;21(1):121. doi: 10.1186/s12905-021-01256-x.
PMID: 33757511DERIVEDSimmons RG, Sanders JN, Geist C, Gawron L, Myers K, Turok DK. Predictors of contraceptive switching and discontinuation within the first 6 months of use among Highly Effective Reversible Contraceptive Initiative Salt Lake study participants. Am J Obstet Gynecol. 2019 Apr;220(4):376.e1-376.e12. doi: 10.1016/j.ajog.2018.12.022. Epub 2018 Dec 18.
PMID: 30576664DERIVEDHiggins JA, Sanders JN, Palta M, Turok DK. Women's Sexual Function, Satisfaction, and Perceptions After Starting Long-Acting Reversible Contraceptives. Obstet Gynecol. 2016 Nov;128(5):1143-1151. doi: 10.1097/AOG.0000000000001655.
PMID: 27741195DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
David K Turok, MD
University of Utah, Department of Obstetrics & Gynecology
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 8, 2016
First Posted
April 12, 2016
Study Start
November 1, 2014
Primary Completion
March 1, 2020
Study Completion
March 1, 2020
Last Updated
April 28, 2021
Record last verified: 2021-04
Data Sharing
- IPD Sharing
- Will not share